Literature DB >> 24613640

Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.

Douglas L Miller1, Chunyan Dou2, Gabe E Owens3, Oliver D Kripfgans2.   

Abstract

Intermittent high intensity ultrasound scanning with contrast microbubbles can induce scattered cavitation microlesions in the myocardium, which may be of value for tissue reduction therapy. Anesthetized rats were treated in a heated water bath with 1.5 MHz focused ultrasound pulses, guided by an 8 MHz imaging transducer. The relative efficacy with 2 or 4 MPa pulses, 1:4 or 1:8 trigger intervals and 5 or 10 cycle pulses was explored in six groups. Electrocardiogram premature complexes (PCs) induced by the triggered pulse bursts were counted, and Evans blue stained cardiomyocyte scores (SCSs) were obtained. The increase from 2 to 4 MPa produced significant increases in PCs and SCSs and eliminated an anticipated decline in the rate of PC induction with time, which might hinder therapeutic efficacy. Increased intervals and pulse durations did not yield significant increases in the effects. The results suggest that cavitation microlesion production can be refined and potentially lead to a clinically robust therapeutic method.
Copyright © 2014 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Cardiac myocyte necrosis; Hypertrophic cardiomyopathy; Myocardial contrast echocardiography

Mesh:

Substances:

Year:  2014        PMID: 24613640      PMCID: PMC4011951          DOI: 10.1016/j.ultrasmedbio.2014.01.001

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  21 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

Review 2.  Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far.

Authors:  Pieter A Dijkmans; Roxy Senior; Harald Becher; Thomas R Porter; Kevin Wei; Cees A Visser; Otto Kamp
Journal:  J Am Coll Cardiol       Date:  2006-11-09       Impact factor: 24.094

3.  Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.

Authors:  Micheline Monteiro de Resende; Alison Jessica Kriegel; Andrew Seth Greene
Journal:  J Cardiovasc Pharmacol       Date:  2006-12       Impact factor: 3.105

4.  Simulation of diagnostic ultrasound image pulse sequences in cavitation bioeffects research.

Authors:  Douglas L Miller; Chunyan Dou; Roger C Wiggins
Journal:  J Acoust Soc Am       Date:  2007-10       Impact factor: 1.840

Review 5.  Bioeffects considerations for diagnostic ultrasound contrast agents.

Authors:  Douglas L Miller; Michalakis A Averkiou; Andrew A Brayman; E Carr Everbach; Christy K Holland; James H Wible; Junru Wu
Journal:  J Ultrasound Med       Date:  2008-04       Impact factor: 2.153

Review 6.  Contemporary treatment of hypertrophic cardiomyopathy.

Authors:  Ali J Marian
Journal:  Tex Heart Inst J       Date:  2009

7.  Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats.

Authors:  Douglas L Miller; Peng Li; Chunyan Dou; David Gordon; Chris A Edwards; William F Armstrong
Journal:  Radiology       Date:  2005-10       Impact factor: 11.105

8.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

9.  Extracardiac ablation of the left ventricular septum in beating canine hearts using high-intensity focused ultrasound.

Authors:  Ryo Otsuka; Kana Fujikura; Yukio Abe; Kazue Okajima; Todd Pulerwitz; David J Engel; Robert Muratore; Jeffrey A Ketterling; Andrew Kalisz; Robert Sciacca; Charles Marboe; Genghua Yi; Jie Wang; Shunichi Homma
Journal:  J Am Soc Echocardiogr       Date:  2007-06-25       Impact factor: 5.251

10.  Myocardial injury induced by ultrasound-targeted microbubble destruction: evidence for the contribution of myocardial ischemia.

Authors:  David Vancraeynest; Xavier Havaux; Agnès Pasquet; Bernhard Gerber; Christophe Beauloye; Patrick Rafter; Luc Bertrand; Jean-Louis Vanoverschelde
Journal:  Ultrasound Med Biol       Date:  2008-12-24       Impact factor: 2.998

View more
  11 in total

1.  Pulmonary Capillary Hemorrhage Induced by Fixed-Beam Pulsed Ultrasound.

Authors:  Douglas L Miller; Chunyan Dou; Krishnan Raghavendran
Journal:  Ultrasound Med Biol       Date:  2015-04-29       Impact factor: 2.998

2.  Characterization of macrolesions induced by myocardial cavitation-enabled therapy.

Authors:  Yiying I Zhu; Douglas L Miller; Chunyan Dou; Oliver D Kripfgans
Journal:  IEEE Trans Biomed Eng       Date:  2014-10-22       Impact factor: 4.538

3.  Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.

Authors:  Douglas L Miller; Chunyan Dou; Xiaofang Lu; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2015-04-15       Impact factor: 2.998

4.  Maturation of Lesions Induced by Myocardial Cavitation-Enabled Therapy.

Authors:  Xiaofang Lu; Douglas L Miller; Chunyan Dou; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2016-04-14       Impact factor: 2.998

5.  Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle.

Authors:  Douglas L Miller; Xiaofang Lu; Chunyan Dou; Yiying I Zhu; Rachael Fuller; Kristina Fields; Mario L Fabiilli; Gabe E Owens; David Gordon; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2018-04-19       Impact factor: 2.998

Review 6.  Emerging non-cancer applications of therapeutic ultrasound.

Authors:  Meaghan A O'Reilly; Kullervo Hynynen
Journal:  Int J Hyperthermia       Date:  2015-03-20       Impact factor: 3.914

7.  Frequency Dependence of Petechial Hemorrhage and Cardiomyocyte Injury Induced during Myocardial Contrast Echocardiography.

Authors:  Douglas L Miller; Xiaofang Lu; Mario Fabiilli; Kristina Fields; Chunyan Dou
Journal:  Ultrasound Med Biol       Date:  2016-04-26       Impact factor: 2.998

8.  Timing of high-intensity pulses for myocardial cavitation-enabled therapy.

Authors:  Douglas L Miller; Chunyan Dou; Gabe E Owens; Oliver D Kripfgans
Journal:  J Ther Ultrasound       Date:  2014-10-02

9.  Quantitative assessment of damage during MCET: a parametric study in a rodent model.

Authors:  Yiying I Zhu; Douglas L Miller; Chunyan Dou; Xiaofang Lu; Oliver D Kripfgans
Journal:  J Ther Ultrasound       Date:  2015-10-16

10.  Multiple ultrasound cavitation-enabled treatments for myocardial reduction.

Authors:  Douglas L Miller; Xiaofang Lu; Chunyan Dou; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  J Ther Ultrasound       Date:  2017-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.